文献速递临床试验与 GCP新药、器械与细胞基因治疗研发基础与转化研究

催产素增强动机性访谈团体治疗用于男男性行为者甲基苯丙胺使用障碍:随机对照试验研究方案

Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-02-21

本研究为随机双盲安慰剂对照试验,计划招募50名来自美国旧金山社区健康项目的男男性行为者(MSM),随机1:1接受每周一次共六次动机性访谈团体治疗(MIGT),同时鼻内给予催产素40 IU或安慰剂。主要结局为治疗 session 出席率,次要结局包括团体凝聚力、焦虑、心理生理学及兴奋剂渴求与使用。该研究为首个在人类甲基苯丙胺使用障碍(MUD)中测试催产素效果的研究。

要点

  • 催产素40 IU鼻内给药联合MIGT,每周一次共六次,随机双盲安慰剂对照。
  • 研究对象为50名正在开始MUD治疗的MSM,来自旧金山社区健康项目。
  • 主要结局为session出席率,次要结局包括团体凝聚力、焦虑、心理生理学及兴奋剂渴求与使用。

核心结论

  • 该方案旨在首次在人类MUD中检验催产素增强心理社会干预的效果,尝试桥接动物模型数据与临床治疗需求。

研究设计与样本

  • 随机、双盲、安慰剂对照试验,计划招募50名MSM,随机1:1接受六次每周MIGT联合催产素40 IU或安慰剂鼻内给药。

关键数值与推荐

  • 催产素或安慰剂40 IU鼻内给药,联合每周一次共六次MIGT。
  • 主要结局为session出席率;其他结局包括团体凝聚力、焦虑、心理生理学及兴奋剂渴求与使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of methamphetamine use disorder (MUD) in the United States has risen dramatically in the past four decades and is concentrated in populations such as men who have sex with men (MSM). Despite the public health consequences of MUD, there are no FDA-approved psychopharmacological treatments. Psychosocial treatment alone has been shown to reduce methamphetamine use, but high attrition rates limit treatment efficacy. Promising findings from animal models of MUD using exogenous oxytocin, a social neuropeptide, have set the stage for translational work. Along with unique anti-addiction effects, oxytocin holds a primary role in enhancing social salience and modulating stress. In humans, oxytocin administration, combined with evidence-based psychosocial interventions, may act synergistically to improve addiction treatment outcomes and improve retention rates in current MUD treatment. METHODS/DESIGN: We are conducting a randomized, double-blind, placebo-controlled trial of oxytocin-enhanced motivational interviewing group therapy (MIGT). Oxytocin or placebo 40 IU is administered intranasally in conjunction with six, weekly MIGT sessions. We will recruit 50 MSM, initiating treatment for MUD from specialized community health programs in San Francisco, CA, USA. Individuals will be randomized (1:1) to receive six, weekly sessions of MIGT with or without oxytocin. Our primary outcome is session attendance. Other outcomes of interest include: measures of group cohesion, anxiety, psychophysiology, and stimulant craving and use. DISCUSSION: This will be the first study of oxytocin's effects in humans with MUD. Findings from this novel protocol will attempt to bridge existing animal data with the need for innovative clinical treatments for MUD, inform the growing field of pharmacologically-enhanced psychotherapy, and help to elucidate mechanisms behind oxytocin's potential anti-addiction effects. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT02881177 . Registered on 26 August 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Stauffer CS, Moschetto JM, McKernan SM, et al. Oxytocin-enhanced motivational interviewing group therapy for methamphetamine use disorder in men who have sex with men: study protocol for a randomized controlled trial. Trials. 2019. PMID: 30791944. doi:10.1186/s13063-019-3225-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。